Skip to main content
SpringerLink
Log in
Book cover

Therapie des Harnblasenkarzinoms pp 63–86Cite as

Lokale Therapiekonzepte beim Harnblasenkarzinom

a) Intravesikale Zytostatikainstillation

b) Integrierte Behandlung durch intraarterielle Zytostatikainfusion und transurethrale Hochfrequenzhyperthermie

  • Chapter

Zusammenfassung

Die heutigen Möglichkeiten der lokalen Zytostatikatherapie des Harnblasenkarzinoms umfassen: 1. Die intravesikale Zytostatika-Applikation. Hierzu zählt die Harnblaseninstillation und die intratumorale Zytostatikainjektion. 2. Die intraarterielle Zytostatika-Tumor-Infusion. Beide Verfahren sind anwendbar unter kurativer und palliativer Zielsetzung. Kurativ kann ein lokal zur Anwendung kommendes Zytostatikum nur wirksam sein, wenn ein lokal begrenzt wachsender Tumor vorliegt. Im Falle einer Metastasierung ermöglicht die intravesikale Instillation natürlich nur eine Wirkung am Primärtumor. Durch die intraarterielle Cytostase sind je nach anatomischer Blutversorgung des Tumors in den moisten Fällen nur palliative Effekte an Primärtumor und/oder Metastasen möglich.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aigner KR, Link KH, Stemmler S, Warthona M (1985) Intraarterielle Infusion, experimentelle und pharmakokinetische Grundlagen — Klinik. In: Aigner KR (Hrsg) Regionale Chemotherapie der Leber. In: Eckhardt S, Holzner IH, Nagel GA (Hrsg) Beiträge zur Onkologie, Vol 21. Karger, S 84 ff

    Google Scholar 

  2. Aigner KR (1985) Regionale Chemotherapie der Leber. In: Eckhardt S, Holzner IH, Nagel GA (Hrsg) Aigner KR 21. Karger, Übersicht

    Google Scholar 

  3. Anderström C, Johansson S, Nilsson S (1982) The significance of lamina propria invasion on the prognosis of patients with bladder tumours. J Urol 124:23

    Google Scholar 

  4. Aronson KF, Hellekant C, Holmberg I, Rothman U, Teder H (1979) Controlled blocking of hepatic artery flow with enzymatically degradable microspheres combined with oncologic drugs. Eur Surg Res 11:99

    Article  Google Scholar 

  5. Banks MD, Pontes JE, Izbicki JE, Pierce JM Jr (1977) Topical instillation of doxorubicin hydrochloride in the treatment of recurring superficial transitional cell carcinoma of the bladder. J Urol 118:757

    PubMed  CAS  Google Scholar 

  6. Barnes RW, Dick AL, Hadley HL, Johnston OL (1977) Survival following transurethral resection of bladder cancer. Cancer Res 37:2895

    PubMed  CAS  Google Scholar 

  7. Barnes RW, Bergmann T, Hadley H, Love D (1967) Control of bladder tumors by endoscopic surgery. J Urol 97:864

    PubMed  CAS  Google Scholar 

  8. Bateman IC (1955) Chemotherapy of solid tumors with triethylene thiophosphoramide. New Engl J Med 252:879

    Article  PubMed  CAS  Google Scholar 

  9. Bengmark S, Fredlund P, Hafström LO, Vang I (1974) Present experiences with hepatic dearterialisation in liver neoplasm. Prog Surg 13:141

    PubMed  CAS  Google Scholar 

  10. Bichler K-H, Harzmann R, Flüchter StH, Erdmann W (1982) Fortschritte der transurethralen Elektroresektion des Harnblasenkarzinoms. Urologe [A] 21:3

    CAS  Google Scholar 

  11. Bichler K-H, Harzmann R, Flachenecker G, Fastenmeier K, Altenähr R, Gericke D, Flüchter StH (1982) Ergebnisse der lokalen transurethralen Hochfrequenzhyperthermie beim Harnblasenkarzinom. Urologe [A] 21:12

    CAS  Google Scholar 

  12. Bichler KH, Strohmaier WL (1988) Operative Therapie beim Harnblasenkarzinom. In: Bichler K-H, Flüchter StH, Strohmaier WL (Hrsg) Therapie des Harnblasenkarzinoms. Springer, Berlin Heidelberg New York, S 23 ff

    Google Scholar 

  13. Boyd PJR, Burnand KG (1974) Side of bladder tumor recurrence. Lancet 1974 II:1290

    Google Scholar 

  14. Bracken RB, Swanson SA, Johnson DE, DeFuria D, Eschenbach AC, Crooke S (1980) Role of intravesical mitomycin C in management of superficial bladder tumors. Urology 16:11

    Article  PubMed  CAS  Google Scholar 

  15. Bressel M, Kemper K, Städtler F (1969) Urologe [A] 8:73

    CAS  Google Scholar 

  16. Bukowski RM, Montie JE, Lee M, Ganapathi R (1987) Neoadjuvant M-VAC with intraarterial Cis-platin in locally advanced transitional cell carcinoma of the bladder: Phase I/II trial AUA 82th Annual Meeting American Urological Association, Inc. Abstract-Band-Nr. 211, 156 A

    Google Scholar 

  17. Burk K, Troller RM, Pittner P (1983) Rezidivprophylaxe bei oberflächlichen Harnblasenkarzinomen. Urologe [A] 22:332

    Google Scholar 

  18. Burnand KG, Boyd PJR, Mayo ME (1976) Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma. Br J Urol 48:55

    Article  PubMed  CAS  Google Scholar 

  19. Cant JD, Brausi M, Soloway MS (1985) Adjuvant chemotherapy for locally advanced bladder cancer. World J Urol 3:115

    Article  Google Scholar 

  20. Cooper TP, Wheelis FR, Correa RJ, Gibbons RP, Mason JT, Cummings KB (1977) Random mucosal biopsies in the evaluation of patients with carcinoma of the bladder. J Urol 117:46

    PubMed  CAS  Google Scholar 

  21. Davis SS, Illum L, McVie JG, Tomlinson E (1984) Microspheres and drug therapy — Pharmaceutical, immunological and medical aspects. (Übersichtsliteratur Mikrospheren.) Elsevier, Amsterdam New York Oxford

    Google Scholar 

  22. Debryne FMJ, Fössa S, Stoter G (1985) Cisplatin-Metothrexat Kombinations-Therapie bei metastasierendem Blasenkarzinom. Eine EORTC Phase II Studie. Abstrakt 37, Kongreß der Deutschen Gesellschaft für Urologie 37, 32

    Google Scholar 

  23. Denis L, Hendrickx G, Keuppens F (1986) Präoperative Chemotherapie des invasiven Blasenkarzinoms. Verh Ber Dtsch Ges Urol 37:89

    Google Scholar 

  24. Denis L, Viggiano G, Oosterlinck W, Bouffioux C, Sylvester R, de Pauw M, Schröder FH, Members of the EORTC GU-Group (1985) Phase III chemotherapy with thiotepa, Adriamycin and cisplatinum for recurrent superficial bladder tumors. Proc Am Urol Ass, Abstr. Nr. 287

    Google Scholar 

  25. Engelmann UH, Frohneberg D, Thürhoff J, Jacobi HJ (1988) Adriamycin versus mitomycin C in chemoprophylaxis of superficial bladder cancer. — A five year follow-up of a prospective randomized trial. J Urol (im Druck)

    Google Scholar 

  26. England HR, Paris AM, Blandy JP (1981) The correlation of T1 bladder tumour history with prognosis and follow-up requirements. Br J Urol 52:593

    Article  Google Scholar 

  27. Erdmann W-D, Harzmann R, Flüchter StH, Bichler K-H (1984) Lokale Mitomycin-C-Therapie des infiltrierenden Harnblasenkarzinoms. Fortschr Med 102:767

    PubMed  CAS  Google Scholar 

  28. Farrow GM, Utz DC, Rife CC, Greene LF (1977) Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder. Cancer Res 37:2794

    PubMed  CAS  Google Scholar 

  29. Farsund T, Laerum OD, Hörstmak J, Jordfald G (1984) Local chemotherapeutic effects in bladder cancer demonstrated by selective sampling and flow cytometry. J Urol 131:22

    PubMed  CAS  Google Scholar 

  30. Fischer N, Rübben H, Deutz F-J, Lutzeyer W, Naber K, Carl P, Opelt B, Lymberopoulos S, Peters H-J, Leusch G, Möllhoff H, Wildberger JE, Pierlitz E (1986) Intravesikale Chemorezidivprophylaxe superfizialer Blasenkarzinome mit Adriamycin. Yerh Ber Dtsch Ges Urol 37:25

    Google Scholar 

  31. Flüchter StH, Harzmann R, Hlobil H, Erdmann W, Bichler K-H (1982) Lokale Chemotherapie des Harnblasenkarzinoms mit Mitomycin. Urologe [A] 21:24

    Google Scholar 

  32. Flüchter StH, Bichler K-H, Harzmann R, Erdmann D (1982) Klinische Erfahrungen mit der lokalen Mitomycin-Therapie oberflächlicher Urothelkarzinome der Harnblase. Onkologie 5:42

    Article  PubMed  Google Scholar 

  33. Flüchter StH, Hlobil H, Harzmann R, Rothe KF, Bichler K-H (1983) Serum- und Gewebe-Mitomycin-C-Spiegel nach intravesikaler Instillation. Urol Int 38:321

    Article  PubMed  Google Scholar 

  34. Flüchter StH, Bichler K-H, Hlobil H, Walter E (1985) Local and intraarterial chemotherapy of bladder cancer with Mitomycin-C. In: Matouschek E (ed) Endourology, proceedings of the third congress of the international society of urologic endoscopy. BuA, Steinbrück, 221 ff

    Google Scholar 

  35. Flüchter StH, Bichler K-H, Walter E, Laberke H-G, Müller-Schauenburg W, Nelde HJ, Rothe KF (1986) Intraarterielle synchrone Mikrospheren-Zytostatika-Infusion urologischer Tumoren. In: Nagel GH, Sauer R, Schreiber HW (Hrsg) Aktuelle Onkologie 28, Mitomycin 85, Klinik — Pharmakologie — Perspektive. Zuckschwerdt, p 172 ff

    Google Scholar 

  36. Flüchter StH, Bichler K-H, Laberke H-G, Walter E, Müller-Schauenburg W, Schulz D (1988) Klinische Problematik und morphologische Aspekte der lokalen Mikrospheren-Zytostatikum-Therapie in der Urologie. Z ART (in Druck)

    Google Scholar 

  37. Fujita H (1971) Comparative studies on the blood level, tissue distribution, excretion and inactivation of anticancer drugs. Jpn J Clin Oncol 12:151

    Google Scholar 

  38. Fujita H, Kimura K (1966) Methode zur Bestimmung von Mitomycin C in Blutbanken oder Gewebeproben (japanisch). Gam No Rinsho (Clinical Cancer Chemotherapy) 80:65

    Google Scholar 

  39. Garnick MB, Schade D, Israel M, Maxwell B, Richie JP (1984) Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma. J Urol 131:43

    PubMed  CAS  Google Scholar 

  40. Green DF, Robinson MRG, Glashan R, Newling D, Dalesio O, Smith PH (1984) Does intravesical chemotherapy prevent invasive bladder cancer? J Urol 131:33

    PubMed  CAS  Google Scholar 

  41. Greene LF, Hanash KA, Farrow GM (1973) Benign papillary carcinoma of the bladder. J Urol 110:205

    PubMed  CAS  Google Scholar 

  42. Harrison GSM, Green DF, Newling DWW, Richards B, Robinson MRG, Smith PH (1983) A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer. Br J Urol 55:676

    Article  PubMed  CAS  Google Scholar 

  43. Harzmann R (1980) Lokale Hochfrequenz-Hyperthermie beim Harnblasenkarzinom. — Tierexperimentelle und klinische Untersuchungen; Monographie. Urban und Schwarzenberg, München Wien Baltimore

    Google Scholar 

  44. Heckl W, Reichert HE, Osterhage HR, Dämmrich J (1986) Oberflächlich wachsende Harnblasentumoren: Progression, Rezidivrate. Verh Ber Dtsch Ges Urol 37:188

    Google Scholar 

  45. Heney NM, Nocks BM, Daly JJ, Prout GR, Newall JB, Griffin PP, Perrone TL, Szyfelbein WA (1982) Ta and T1 bladder cancer; location, recurrence and progression. Br J Urol 54:152

    Article  PubMed  CAS  Google Scholar 

  46. Hohenfellner R (1979) Therapierichtlinien für das Prostatakarzinom. In: Jacobi GH, Altwein JE (Hrsg) Beiträge zur Onkologie: Chemotherapie urologischer Malignome. Karger, Basel München Paris London New York Sydney, S 66

    Google Scholar 

  47. Huland H, Otto U, Droese M, Klöppel G (1984) Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: Influence of recurrence, progression and survival. J Urol 132:27

    PubMed  CAS  Google Scholar 

  48. Huland H, Brachmann W, Hubmann R, Kaufmann EJ, Knipper W (1986) Rezidivprophylaxe oberflächlicher Harnblasenkarzinome, Ergebnisse einer multizentrischen Hamburger Studie. 38. Kongreß der Deutschen Gesellschaft für Urologie, Würzburg, 23.–28. 9. 1986 (Abstract 239)

    Google Scholar 

  49. Imamura K, Yoshida H, Maruyama K, Ikenchi T, Yjima N, Oshino Y, Saito T (1979) Studies of intravesical treatment of bladder tumor with combined Mitomycin-C and Dexamethason. Jpn J Clin Urol 30:241

    Google Scholar 

  50. Jacobi GH (1979) Stellenwert der systemischen Chemotherapie beim fortgeschrittenen Harnblasenkarzinom. Beiträge zur Onkologie 1. In: Jacobi GH, Altwein JE (Hrsg) Chemotherapie urologischer Malignome. Karger, S 141 ff

    Google Scholar 

  51. Jacobs SC, Lawson RK (1982) Pathologie effects of precystectomy therapy with combination intraarterial doxorubicin hydrochloride and local bladder hyperthermia for bladder cancer. J Urol 127:43

    PubMed  CAS  Google Scholar 

  52. Jacobs SC, McCellan SL, Mäher C, Lawson RK (1984) Precystectomy intraarterial cisdiamminedichloroplatinum II with local bladder hyperthermia for bladder cancer. J Urol 131:473

    PubMed  CAS  Google Scholar 

  53. Jakse G, Hofstätter F, Marberger H (1980) Wert der Harnzytologie und der Quadrantenbiopsie bei oberflächlichen Blasenkarzinomen. Aktuel Urol 11:309

    Article  Google Scholar 

  54. Jakse G, Bauer WF, Wieland Jacobi GH (1981) Rezidivprophylaxe durch intravesikale Instillationen mit Adriamycin, Mitomycin-C oder VM-26 beim pTA-1 Blasenkarzinom. Verh Ber Dtsch Ges Urol 32:351

    Google Scholar 

  55. Jakse G, Frommhold H, Marberger H (1983) Combined cis-platinüm and radiation therapy in patients with stages pT3 and pTa bladder cancer: a pilot study. J Urol 129:502

    PubMed  CAS  Google Scholar 

  56. Jakse G, Fritsch E, Frommhold H (1985) Combination of chemotherapy and irradiation for nonresectable bladder carcinoma. World J Urol 3:121

    Article  Google Scholar 

  57. Jones HC, Swinney J (1961) Thiotepa in the treatment of tumors of the bladder. Lancet I: 615

    Google Scholar 

  58. Kamidono S, Fujii A, Hamani G, Nakano Y, Umezu K, Oda Y, Ishigami J (1984) New preoperative chemotherapy for bladder cancer using combination hemodialysis and direct hemoperfusion: Preliminary report. J Urol 131:36

    PubMed  CAS  Google Scholar 

  59. Kato T, Nemoto R, Mori H, Takahashi M, Tamakawa Y (1981) Transcatheter arterial chemoembolisation of renal cell carcinoma with microencapsulated Mitomycin C. J Urol 125:19

    PubMed  CAS  Google Scholar 

  60. Kennedy KA, Rockwell S, Sartorelli AC (1980) Referential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res 40:2356

    PubMed  CAS  Google Scholar 

  61. Kunze E (1984) Die multifaktorielle Mehrstufenkarzinogenese am Harnblasenurothel. In: Bichler K-H, Harzmann R (Hrsg) Das Harnblasenkarzinom — Epidemiologie, Pathogenese, Früherkennung. Springer, Berlin Heidelberg New York Tokyo, S 37

    Google Scholar 

  62. Kurth KH (1987) Persönliche Mitteilungen.

    Google Scholar 

  63. Leyh H, Schütz W, Kuntz RM (1986) Lokale Tumorrezidivprophylaxe mit Mitomycin C bei der Behandlung oberflächlicher Harnblasentumoren. Verh Ber Dtsch Ges Urol 37:202

    Google Scholar 

  64. Lindberg B, Lote K, Teder H (1984) Biodegradable starch micro spheres — A new medical tool. In: Davis SS, Illum L, McVie IG, Tomlinson E: Microspheres and drug therapy. Pharmaceutical, immunological and medical aspects. Elsevier Science Publishers BV. S 153 ff

    Google Scholar 

  65. Lindeil B, Aronson KF, Rothman U (1977) Repeated arterial embolisation of rat livers by degradable microspheres. Eur Surg Res 9:347

    Article  Google Scholar 

  66. Löffler T, Aigner KH, Hausamen TK (1,985) Cisplatin, Mitomycin and 5FU tissue concentrations in hepatic metastases after intraarterial chemotherapy alone and with use of starch microspheres. Proc AACR 26:156

    Google Scholar 

  67. Melicow MM (1952) Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy. J Urol 68:261

    PubMed  CAS  Google Scholar 

  68. Mishina T, Oda K, Murata S, Ooe H, Mori Y, Takahashi T (1975) Mitomycin C bladder instillation therapy for bladder tumors. J Urol 114:217

    PubMed  CAS  Google Scholar 

  69. Mishina T, Murata S, Tanaka S, Miyaboda K, Watanabe K (1975) Experimental and clinical study on the bladder cancer, the third report. J Kyoto Pref Univ Med 84:613

    Google Scholar 

  70. Mishina T, Watanabe H (1979) Mitomycin C bladder instillation therapy for bladder tumors. In: Mitomycin C current status and new developments. Academic Press, New York, San Francisco, London, Chapter 22

    Google Scholar 

  71. Murphy WM, Soloway MS, Crabtree WN (1981) The morphologic effects of Mitomycin C in mammalian urinary bladder. Cancer 47:2567

    Article  PubMed  CAS  Google Scholar 

  72. Murphy WM, Soloway MS, Finebaum PJ (1981) Pathological changes associated with topical chemotherapy for superficial bladder cancer. J Urol 126:461

    PubMed  CAS  Google Scholar 

  73. Nishiura T (1968) Effects of Mitomycin-C intracavitary therapy for recurrent bladder cancers. Igako Ayuni 65:637

    Google Scholar 

  74. Norpoth K (1984) Grundlagen der Prävention bösartiger Urotheltumoren. In: Bichler K-H, Harzmann R (eds) Das Harablasenkarzinom — Epidemiologie, Pathogenese, Früherkennung. Springer, Berlin Heidelberg New York Tokyo, S 1

    Google Scholar 

  75. Ogawa H (1969) Bladder instillation therapy of bladder tumors with an antitumor drug. Mitomycin C, and a radioisotope p32. I. Fundamental study on bladder instillation of Mitomycin C and p32. Jpn J Urol 60:717

    CAS  Google Scholar 

  76. Ogawa H (1969) Bladder instillation therapy of bladder tumors with an antitumor drug, Mitomycin C, and a radioisotope p32. III. Fundamental and clinical studies on bladder instillation of MMC and p32 (histological changes). Jpn J Urol 60:728

    CAS  Google Scholar 

  77. Ogawa H (1969) Bladder instillation therapy of bladder tumors with an antitumor drug, Mitomycin C, and a radioisotope p32. IV. Clinical studies on bladder instillation of MMC (plasma level and clinical results). Jpn J Urol 60:746

    CAS  Google Scholar 

  78. Page BH, Levison VB, Curwen MP (1978) The side of recurrence of non-infiltrating bladder tumours. Br J Urol 50:237

    Article  PubMed  CAS  Google Scholar 

  79. Rassweiler J, Miller K, Gumpinger R, Fuchs G, Eisenberger F (1986) Langzeitchemoprophylaxe beim oberflächlichen Harnblasenkarzinom — eine kritische Zwischenbilanz nach 2 Jahren. Verh Ber Dtsch Ges Urol 37:207

    Google Scholar 

  80. Reich SD (1979) Clinical pharmacology of Mitomycin C. In: Mitomycin C current status and new developments, Chapter 27. Academic Press, New York San Francisco London

    Google Scholar 

  81. Rockwell S, Kennedy KA, Sartorelli AC (1979) Mitomycin C as a prototype bioreductive alkylating agent: in vitro studies of metabolism and cytotoxicity. Int J Radiat Oncol Biol Phys 5:1275

    Google Scholar 

  82. Rübben H, Dahm HH, Lutzayer W (1981) Rezidivhäufigkeit und Tumorprogression superfizialer Harnblasenkarzinome. Urologe [A] 20:211

    Google Scholar 

  83. Sai E, Hayakava T (1968) Intracavitary therapy for bladder tumors using Mitomycin C. Med Consult New Remedies 5:1933

    Google Scholar 

  84. Saito S (1969) Topical chemotherapy for bladder carcinoma. J West Jpn Soc Urol 31:501

    Google Scholar 

  85. Schade RO, Swinney J (1968) Precancerous changes in bladder epithelium. Lancet 11:943

    Article  Google Scholar 

  86. Scher HI, Fair WR, Yagoda A, Sternberg CN, Morse MJ, Herr HW, Sogani PC, Hollander PS, Whitemore WF Jr (1987) Clinical downstaging after neoadjuvant M-VAC for transitional cell carcinoma of the urothelium. AUA 82th Annual Meeting American Urological Association, Inc. Abstract-Band-Nr. 213, S 157 A

    Google Scholar 

  87. Schulman CC, Robinson MR, Denis L, Smith PH, Viggiano G, de Pauw M, Dalesio P, Sylvester R, Members of the EORTC GU-Group (1982) Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an Epipodophyllotoxin (VM26) and TUR alone. Eur Urol 18:207

    Google Scholar 

  88. Schultheis K-H, Harbach H (1984) Untersuchungen über die Pharmakokinetik von Mitomycin nach intraarterieller Infusion bzw. Chemoembolisation. In: Nagel GA, Sauer R, Schreiber HW (Hrsg) Aktuelle Onkologie 10. In: Nagel GA, Bartsch H-H, Bach F (Hrsg) Mitomycin C, Profil eines Zytostatikums. Zuckschwerdt, p 119 ff

    Google Scholar 

  89. Seiberg W (1964) Zur Morphologie der Harnblasencarcinome. Urologe [A] 3:72

    Google Scholar 

  90. Semple JE (1948) Papillomata of the bladder treated with podophyllin, preliminary report. Br Med J 1:1235

    Article  PubMed  CAS  Google Scholar 

  91. Sen SE, Zincke H, Keating JP, Hahn RG (1987) Neoadjuvant chemotherapy (M-VAC) prior to cystectomy for high stage (T2-T4NxM0) bladder cancer: Do local pathologic findings suggest a potential for bladder salvage. AUA 82th Annual Meeting American Urological Association, Inc Abstract-Band-Nr 212, p 156 A

    Google Scholar 

  92. Shida K, Tatani M, Kato N, Urano E, Oogoshi M, Tazaki H, Ozeki Z, Mitsunaga S, Yajima H, Nakagami Y, Nakamura Y (1967) Treatment of the bladder cancer with instillation of Mitomycin C. Jpn J Clin Urol 21:1057

    Google Scholar 

  93. Shipley WU, Einstein AB, Prout GR, Brannen GE, Flanagan MJ, Koontz WE, Pearse H, Barton BA, Englander L, Weinstein R (1987) Cisplatin and full-dose irradiation for patients with invasive bladder carcinoma: The national bladder cancer group experience. AUA 82th Annual Meeting American Urological Association, Inc. Abstract-Band-Nr 208, p 155 A

    Google Scholar 

  94. Soloway MS, Murphy W, Rao MK, Cox C (1978) Serial multiple-site biopsies in patients with bladder cancer. J Urol 120:57

    PubMed  CAS  Google Scholar 

  95. Soloway MS (1980) Rationale for intensive intravesical chemotherapy for superficial bladder cancer. J Urol 123:461

    PubMed  CAS  Google Scholar 

  96. Soloway MS (1980) The management of superficial bladder cancer. Cancer [suppl 7] 45:1856

    CAS  Google Scholar 

  97. Soloway MS, Murphy WM, De Furia MD, Crooke S, Finebaum P (1981) The effect of Mitomycin C on superficial bladder cancer. J Urol 125:646

    PubMed  CAS  Google Scholar 

  98. Soloway MS, Masters S (1980) Urothelial susceptibility to tumor cell implantation. Influence of cauterization. Cancer 46:1158

    CAS  Google Scholar 

  99. Sternberg CN, Yagoda A, Scher HI, Herr HW, Morse MJ, Sogani PC, Watson RC, Hollander PS, Withmore WF Jr (1987) Long-term survival in advanced urothelial cancer with M-VAC: The first two years of accrual. AUA 82th Annual Meeting American Urological Association, Inc Abstract-Band-Nr 214, p 157 A

    Google Scholar 

  100. Stoter G (1985) Chemotherapy for metastatic bladder carcinoma. World J Urol 3:110

    Article  Google Scholar 

  101. Streffer C (1987) Hyperthermia and the therapy of malignant tumors. Recent results in cancer research 104 (Übersicht). Springer, Berlin Heidelberg New York London Paris Tokyo

    Google Scholar 

  102. Studer UE, Wallace DMA, Ruchti E, Zingg EJ (1985) The role of pelvic lymphnode metastases in bladder cancer. World J Urol 3:98

    Article  Google Scholar 

  103. Tuma RF, Forsberg IO, Agerup B (1982) Enhanced uptake of actinomycin D in the dog kidney by simultaneous injection of degradable starch microspheres into the renal artery. Cancer 50:1

    Article  PubMed  CAS  Google Scholar 

  104. Tuma RF (1984) The use of degradable starch microspheres for transient occlusion of blood flow and for drug targeting to selected tissues. In: Davis SS, Illum L, McVie JG, Tomlinson E (eds) Microspheres and drug therapy. Pharmaceutical, immunological and medical aspects. Elsevier Science Publishers B.V., Amsterdam New York Oxford, p 189 ff

    Google Scholar 

  105. Veenema RJ (1962) Bladder carcinoma treated by direct instillation of Thiotepa. J Urol 88:60

    PubMed  CAS  Google Scholar 

  106. Wallace DMA, Hindmarsh JR, Webb JN, Busuttil A, Hargreave IB, Newsom JE, Chisholm GD (1979) Br J Urol 51:535

    Article  PubMed  CAS  Google Scholar 

  107. Watkins E Jr, Kahzei AM, Nahra KS (1970) Surgical basis for arterial infusion chemotherapy and disseminated carcinoma of the liver. Surg Gynecol Obstet 130:580

    Google Scholar 

  108. Whitmore WF (1983) Management of invasive bladder neoplasms. Semin Urol 1:34

    PubMed  Google Scholar 

  109. Zingg EJ (1982) Maligne Tumoren der Harnblase. In: Hohenfellner R, Zingg EJ (Hrsg) Urologie in Klinik und Praxis, Band 1, Thieme, S. 520 ff

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Urologie, Eberhard-Karls-Universität Tübingen, Calwer Straße, D-7400, Tübingen, Germany

    St. H. Flüchter, K.-H. Bichler & D. Schulz

  2. Pathologisches Institut Leonberg, Rutesheimerstr. 50/1, D-7250, Leonberg, Germany

    H. D. Laberke

  3. Radiologische Klinik, Eberhard-Karls-Universität Tübingen, D-7400, Tübingen, Germany

    E. Walter

Authors
  1. St. H. Flüchter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K.-H. Bichler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. D. Laberke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Schulz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Walter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Urologie der, Eberhard-Karls-Universität Tübingen, Calwer Straße 7, D-7400, Tübingen, Germany

    Karl-Horst Bichler , Stephan Heribert Flüchter  & Walter Ludwig Strohmaier ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Flüchter, S.H., Bichler, KH., Laberke, H.D., Schulz, D., Walter, E. (1988). Lokale Therapiekonzepte beim Harnblasenkarzinom. In: Bichler, KH., Flüchter, S.H., Strohmaier, W.L. (eds) Therapie des Harnblasenkarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72670-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72670-5_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-72671-2

  • Online ISBN: 978-3-642-72670-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation